View Older Stories View More Recent Stories
-
Archrock (AROC) PT Raised to $33 at RBC Capital on Growth Potential
-
Target (TGT) PT Lowered to $151 at RBC Capital Amid Tariffs Pressure
-
CrowdStrike Holdings (CRWD) PT Lowered to $460 at RBC Capital
-
RBC Capital Reiterates Outperform Rating on Airbus SE (AIR:FP) (EADSY)
-
RBC Capital Reiterates Outperform Rating on Chipotle Mexican Grill (CMG), 'Channel checks indicate hot honey chicken could launch online on Thursday'
-
RBC Capital Starts Moonpig Group PLC (MOON:LN) at Outperform
-
RBC Capital Starts Woolworths Group Ltd (WOW:AU) at Sector Perform
-
RBC Capital Starts Coles Group Ltd. (COL:AU) (CLEGF) at Outperform
-
The world will 'get by' and investors should 'buy the dip', Larry Fink says
-
Exclusive-Kazakh overproduction helped sway OPEC+ to approve output hike, sources say
-
Ardent Health Partners Inc (ARDT) PT Lowered to $21 at RBC Capital Despite 'Solid 4Q'
-
Sunnova (NOVA) PT Lowered to $0.75 at RBC Capital on 'Limited Visibility'
-
RBC Capital on Shift4 Payments (FOUR): 'Global Blue Acquisition Adds Opportunity for Growth'
-
Okta, Inc (OKTA) PT Raised to $120 at RBC Capital
-
RBC Capital: 'GitLab Inc (GTLB) Remains Our Top SMID-Cap Idea'
-
RBC on Biohaven Pharmaceutical Holding (BHVN): 'Stock Reaction Overdone On Bipolar Miss'
-
Cardinal Energy Ltd. Announces Closing of $45 Million Bought Deal Offering of Senior Subordinated Unsecured Debentures
-
BNY Mellon (BK) Announces Pricing of Public Offering of $500 mln Depositary Shares
-
BNY Announces Pricing of Public Offering of $500,000,000 of Depositary Shares Representing Interests in Preferred Stock
-
Webster Financial Corporation to Speak at RBC Capital Markets Global Financial Institutions Conference
-
Form MA-I/A RBC Capital Markets,
-
Kinder Morgan (KMI) PT Raised to $27 at RBC Capital Amid 'Natural Gas Demand Growth'
-
FS KKR Group (FSK) PT Raised to $22 at RBC on 'Increased Confidence in Dividend Outlook'
-
RBC Capital on Williams-Sonoma (WSM): 'Expecting Another Qtr of Strong EPS Growth'
-
Brown Forman (BF-B) PT Lowered to $44 at RBC Capital Amid 'Near-Term Pressures'
-
Targa Resources (TRGP) PT Raised to $221 at RBC Capital on 'Demand Driven Growth'
-
RBC Capital Upgrades Coloplast A/S (COLOB:DC) (CLPBY) to Outperform
-
Toronto-Dominion Bank (TD:CN) (TD) PT Raised to Cdn$87 at RBC Capital
-
Canadian Imperial Bank of Commerce (CM:CN) (CM) PT Raised to Cdn$108 at RBC Capital
-
VSE Corporation (VSEC) PT Raised to $140 at RBC Capital on 'Better-than-Expected 2025 Outlook'
-
Ligand Pharma (LGND) PT Raised to $153 at RBC Capital Following a 'Strong Quarter'
-
Beacon Roofing Supply (BECN) PT Lowered to $124 at RBC Capital
-
HEICO (HEI) PT Raised to $285 at RBC Capital, Reflecting Raised Estimates
-
Elastic NV. (ESTC) PT Raised to $140 at RBC Capital; 'Stop Searching, GenAI is Here'
-
RBC Capital Reiterates Outperform on Bloom Energy Corp. (BE) on the 'Strong Demand Opportunity'
-
RBC Capital Reiterates Outperform Rating on Autodesk (ADSK) Following a 'Strong Quarter'
-
Addus HomeCare (ADUS) PT Lowered to $133 at RBC Capital; 'We Continue to Believe Stock Is Oversold'
-
RBC Capital on Descartes (DSGX): 'Tariff Uncertainty Is a Likely Tailwind'
-
Federated Hermes, Inc.'s CEO to participate in 2025 RBC Capital Markets Global Financial Institutions Conference
-
Blue Owl Capital Inc. to Present at the 2025 RBC Capital Markets Financial Institutions Conference
-
RBC Capital Upgrades Welltower, Inc. (WELL) to Outperform
-
Old National Bancorp to Present at the Raymond James & Associates and RBC Capital Markets Conferences
-
Old National Bancorp to Present at the Raymond James & Associates and RBC Capital Markets Conferences
-
BRIXMOR PROPERTY GROUP PRICES OFFERING OF SENIOR NOTES
-
Form MA-I RBC Capital Markets,
-
Sanctions, tariffs make OPEC+ hesitant on April oil hike, sources say
-
Sweetgreen Inc (SG) PT Lowered to $30 at RBC Capital, Reflecting 'NT Challenges'
-
RBC on Verisk Analytics (VRSK): 'Stock Wobbles Under Weight of Impressive Subscriptions and Pricing Predicaments'
-
Snowflake Inc. (SNOW) PT Raised to $221 at RBC Capital on 'Higher Estimates'
-
RBC on Sarepta Therapeutics (SRPT): 'Overall We View Shares as Fundamentally Undervalued'; PT Lowered
